4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-25-063840
President, CEO and CFO bought 5,000 shares at an average $0.57 ($2,835)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinn William P. President, CEO and CFO | 2024-12-16 | Purchase | +2,500 | $0.50 | $1,241 | 41,272 | D: show line 1 in the form |
| Quinn William P. President, CEO and CFO | 2024-06-06 | Purchase | +2,500 | $0.64 | $1,594 | 38,772 | D: show line 2 in the form |
| Open-market purchases · 5,000 sh · avg $0.57 · $2,835 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Quinn William P. President, CEO and CFO | 2025-05-01 | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…